About Us

Message from Top Management

We will be a Specialty Biotech CDMO (*)

MicroBiopharm Japan Co., Ltd. wishes to contribute to the healthy and prosperous lives of people all around the world by leveraging biotechnology in particular with the power of microorganisms.

MicroBiopharm Japan, celebrated our 10th anniversary in July 2021. As a manufacturer of APIs (active pharmaceutical ingredients) including anti-cancer drugs as well as active ingredients for foods, feeds, and agricultural products, we have more than 50 years of experiences in microbial fermentation and microbial transformation that has been cultivated through the pharmaceutical and chemical business by our predecessor, Mercian Corporation. While sustaining a firm basement in these businesses, we are also accelerating business development in the field of biopharmaceuticals, which is a new modality that is being rapidly expanded fueled by innovative biotechnologies. We possess unique technologies cultivated over our long history allowing us to synthesize high potent pharmaceutical substances, to extract valuable substances using microbial resources, and to implement hydroxylation via our P450 library. We are also proud of deepening our quality culture and evolving EHS (environment, health and safety) skills both in hardware and software. Through these comprehensive strengths, we have been successfully gaining trust of our domestic as well as international customers.

After more than 10 years of operation as an independent company, MicroBiopharm Japan is stepping in the next stage. We are committed to grow sustainably as a specialty biopharmaceutical CDMO that provide high quality chemical substances by microbial fermentation and transformation as well as innovative biopharmaceutical molecules for a new modality. On behalf of the employees of MicroBiopharm Japan, I would like to ask for the continued support of all our stakeholders, including our customers, partners, and local communities.

Atsushi Shiota
President and Chief Executive Officer
MicroBiopharm Japan Co., Ltd.

* Contract Development and Manufacturing Organization